Hints and tips:
...Nick Leschly, Bluebird’s chief executive, said the new treatments were forcing the industry to explore new ways to spread the cost....
...“All of a sudden now, you can barely get space — all the big pharmas have come in and taken huge space,” says Nick Leschly, chief executive of Bluebird Bio, a biotech group based in Cambridge....
...I was inspired by our keynote speakers Halle Tecco, managing director of Rock Health, and Nick Leschly, chief executive of Bluebird Bio, and by fellow student David Fajgenbaum who spoke on his experience...
International Edition